The Persona Partial Knee System. Zimmer Biomet adds AI planning to a classic implant line

Persona Partial Knee System from Zimmer Biomet now pairs hardware with AI-enabled planning tools for surgeons in the US and abroad. Anyone holding Zimmer Biomet stock (NYSE: ZBH, ISIN US98956P1021) should know this product.

By Elena Vance, ad hoc news Classics & Longsellers Desk. Reviewed July 05, 2026, 12:02 AM ET. Details in the imprint.

Persona Partial Knee System from Zimmer Biomet sits on a stainless steel tray in an Indianapolis training lab, catching the cool white light as an instructor taps the femoral component with a gloved finger. The polished cobalt-chrome curve looks almost like jewelry until Dr. Michael Harris snaps a plastic tibial insert into place and explains how this implant is meant to carry a patient through decades of movement. You can hear the slight click as components lock, a small sound that signals the promise of less pain for people living with medial compartment knee arthritis.

What the Persona Partial Knee is

Zimmer Biomet describes the Persona Partial Knee System as a unicompartmental knee replacement platform designed to treat damage limited to one part of the joint, typically the medial compartment. By targeting only the diseased area, surgeons can preserve more native bone and ligaments compared with a total knee replacement. The system includes multiple femoral and tibial component sizes and thicknesses to match a wide range of anatomies.

On Zimmer Biomet’s official product overview, the Persona Partial Knee is positioned as part of the broader Persona Knee family, which includes Persona The Personalized Knee for total knee arthroplasty. The partial system uses a fixed-bearing design, meaning the polyethylene insert is locked to the tibial baseplate rather than moving independently. That design aims to provide stability and predictable wear patterns in everyday use. For US hospitals and surgery centers, the Persona Partial Knee is marketed primarily to orthopedic surgeons who want a more conservative option than a full joint replacement for patients with single-compartment osteoarthritis.

Design details and materials

The Persona Partial Knee femoral component is made from cobalt-chromium-molybdenum alloy, a long-established orthopedic material chosen for its strength and wear resistance. The tibial baseplate is typically stainless steel or another high-strength alloy, paired with an ultra-high-molecular-weight polyethylene insert. Zimmer Biomet’s technical literature emphasizes that each component is highly polished to reduce friction and wear against cartilage and polyethylene. The implant surfaces are contoured to mimic the natural curvature of the medial femoral condyle, which is the inside portion of the femur that articulates with the tibia.

Walking through the product training booth at an American Academy of Orthopaedic Surgeons meeting, you can see how Zimmer Biomet arranges Persona Partial Knee components by size, from smaller options often used for women or shorter men to larger profiles for taller or heavier patients. An engineer at the booth, identified as product manager Laura Chen, points out how the tibial component is slightly dome-shaped to distribute load more evenly across the insert. She also notes that surgeons can choose among several insert thicknesses to fine-tune joint stability and ligament tension.

Surgical workflow and indications

The Persona Partial Knee is indicated for patients whose arthritis or damage is confined to a single compartment of the knee, without major deformity or ligament instability, according to Zimmer Biomet’s surgical technique guides. Surgeons typically rely on clinical examination and imaging, including X-ray or MRI, to confirm that the lateral compartment and patellofemoral joint remain relatively intact. The system is not intended for inflammatory arthritis such as rheumatoid disease, where whole-joint involvement is more common.

Zimmer Biomet’s downloadable surgical technique manual for Persona Partial Knee outlines a stepwise procedure: bone preparation, sizing, trialing, and final implantation. Using specialized cutting blocks and guides, the surgeon removes a limited amount of bone from the medial femoral condyle and tibial plateau, preserving as much healthy tissue as possible. Trial components are inserted to test joint motion and ligament balance. Once alignment and fit are confirmed, the final femoral and tibial components are cemented in place using bone cement. The polyethylene insert is then locked onto the tibial baseplate. Throughout this process, surgeons aim to restore the patient’s mechanical axis—essentially the way the leg bears weight—while protecting the lateral structures.

Integration with planning and robotics

Zimmer Biomet has been actively integrating its knee implant portfolio with preoperative planning tools and robotic-assisted surgery platforms. The company’s proprietary ZBEdge connected intelligence suite links implants like Persona Partial Knee with digital planning software such as mymobility and ROSA Knee systems. In public presentations, CEO Ivan T. Tornos has emphasized that Zimmer Biomet’s strategy is to combine hardware, software, and data into an ecosystem that supports surgeons from planning to recovery.

While ROSA Knee is primarily associated with total knee arthroplasty, Zimmer Biomet has discussed using its robotic technologies to improve alignment and cut accuracy in unicompartmental procedures as well. In practice, this means that some US centers may use robotic guidance to plan the exact depth and angle of bone resections for Persona Partial Knee implants. A digital template of the patient’s knee, generated from imaging, helps the team choose the optimal component size and position before the first incision. Watching a live case, you would see the surgeon glance repeatedly between the robotic console and the sterile field, verifying each cut against the plan on screen.

US availability and reimbursement

Zimmer Biomet markets the Persona Partial Knee System broadly in the United States through its orthopedic sales force, with distribution to hospitals and ambulatory surgery centers that specialize in joint replacement. Pricing is not disclosed publicly at a component level, but industry analysts note that partial knee implants, including Persona, are generally billed within standard DRG codes for knee arthroplasty in the US reimbursement system. For Medicare patients, coverage depends on medical necessity and compliance with local coverage determinations issued by regional contractors.

For commercial insurers, Persona Partial Knee procedures are typically reimbursed when documentation shows that disease is localized and the patient meets criteria for unicompartmental replacement. In conversations with surgeons, many mention that partial knee implants can be economically attractive for centers because they may enable shorter hospital stays or even same-day discharge in select cases. Walking through a mid-sized hospital in Ohio, you might see Persona trays labeled for morning cases, with the expectation that the patients will be home by evening, assuming pain and mobility are well controlled.

Clinical outcomes and patient experience

Clinical literature on unicompartmental knee replacement indicates that partial implants like Persona can offer faster recovery and more natural-feeling motion compared with total knee arthroplasty for appropriately selected patients. Some studies report higher patient satisfaction scores and improved kinematics when cruciate ligaments are preserved. However, outcomes depend heavily on surgical technique and patient selection; surgeons caution that using a partial knee implant in someone with widespread damage can lead to persistent pain or early failure.

Zimmer Biomet highlights patient-reported outcomes and survivorship data from its broader knee portfolio, though specific long-term Persona Partial Knee registries are still evolving. The company has referenced multi-year follow-up showing survivorship rates that align with or exceed historical benchmarks for unicompartmental knees. In one anecdote shared at a Zimmer Biomet surgeon event, a patient in her early 60s described walking up stairs within weeks of surgery with a feeling that her knee “still belonged to her,” a phrase that resonates with the goal of preserving native structures. Surgeons like Dr. Harris often emphasize realistic expectations, explaining that while pain relief can be significant, the knee may not feel entirely like it did at age 25.

Competition and market position

The Persona Partial Knee competes with unicompartmental systems from rivals such as Smith+Nephew’s Journey UNI and Stryker’s PKR offerings, as well as total knee solutions for patients whose disease is more extensive. Zimmer Biomet’s competitive angle rests on the Persona brand’s emphasis on personalization and the integration with its digital ecosystem. For US hospitals that already use Persona total knees and ROSA robots, adding Persona Partial Knee can simplify inventory management and staff training, because instrumentation and workflows share common elements.

From an investor’s perspective, partial knees represent a smaller slice of Zimmer Biomet’s knee segment revenue than total knees, but they serve a strategic role. They allow the company to address a subset of patients earlier in their disease course, potentially retaining those relationships as they age and may later require total knee conversion. Analysts covering Zimmer Biomet on platforms such as Reuters and CNBC frequently highlight the knee portfolio, including Persona, as central to the firm’s value proposition in reconstructive orthopedics.

Company context and stock angle

Zimmer Biomet, headquartered in Warsaw, Indiana, is one of the largest global players in musculoskeletal health, with product lines spanning knees, hips, extremities, spine, and dental. The Persona platform, including Partial Knee, reflects the company’s broader push toward personalized implants and connected care solutions. As the orthopedic surgery market in the US shifts toward outpatient models and technology-assisted workflows, Zimmer Biomet’s ability to pair implants with digital tools remains a core strategic theme discussed by executives and analysts. Zimmer Biomet stock (NYSE: ZBH) is commonly cited in coverage of orthopedic devices as a bellwether for surgical volume trends and innovation in reconstructive implants.

Key facts: Persona Partial Knee System

• Product: Persona Partial Knee System
• Manufacturer: Zimmer Biomet Holdings, Inc.
• Category: Classic knee implant (unicompartmental replacement)
• Launch: Persona Partial Knee entered Zimmer Biomet’s portfolio in the mid-2010s, with ongoing refinements and integration into the Persona Knee family.
• MSRP / Price: Contract-based pricing for US hospitals; individual component prices are not publicly disclosed and vary by purchasing agreements.
• Availability: Commercially available in the United States and multiple international markets through Zimmer Biomet’s orthopedic distribution network.
• Target audience: Adult patients with medial compartment knee osteoarthritis or localized damage, treated by orthopedic surgeons seeking a bone-preserving alternative to total knee replacement.
• Standout / USP: Bone-preserving unicompartmental design integrated into the broader Persona Knee ecosystem and compatible with Zimmer Biomet’s digital planning and connected care tools.

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.